Meng-Ru Shen

507 total citations
35 papers, 364 citations indexed

About

Meng-Ru Shen is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Meng-Ru Shen has authored 35 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Meng-Ru Shen's work include Genetic factors in colorectal cancer (5 papers), Cancer Genomics and Diagnostics (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Meng-Ru Shen is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Cancer Genomics and Diagnostics (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). Meng-Ru Shen collaborates with scholars based in Taiwan, China and United Kingdom. Meng-Ru Shen's co-authors include Wen‐Tai Chiu, Peng‐Chan Lin, I‐Hsuan Lin, Hans I‐Chen Harn, Yang‐Kao Wang, Ming‐Jer Tang, Yu‐Min Yeh, Hsi‐Hui Lin, Ching‐Yi Liu and Yu‐Wei Chiou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Meng-Ru Shen

31 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng-Ru Shen Taiwan 10 130 116 88 73 47 35 364
Egor Zindy United Kingdom 14 202 1.6× 110 0.9× 52 0.6× 38 0.5× 21 0.4× 30 464
Shinji Yoshiyama Japan 12 155 1.2× 77 0.7× 45 0.5× 54 0.7× 31 0.7× 21 318
Susanne Vetterkind United States 13 291 2.2× 192 1.7× 27 0.3× 31 0.4× 32 0.7× 16 513
Alexandre Brodovitch France 10 168 1.3× 101 0.9× 26 0.3× 15 0.2× 30 0.6× 19 468
Congying Wu China 7 183 1.4× 58 0.5× 35 0.4× 14 0.2× 74 1.6× 16 352
Lunfeng Zhang China 12 297 2.3× 75 0.6× 31 0.4× 22 0.3× 19 0.4× 18 493
Luca Monti Italy 12 154 1.2× 92 0.8× 32 0.4× 14 0.2× 16 0.3× 18 336
Taryn E. Gillies United States 7 257 2.0× 155 1.3× 44 0.5× 24 0.3× 13 0.3× 9 380
Yulia Epshtein United States 13 282 2.2× 64 0.6× 35 0.4× 12 0.2× 46 1.0× 24 432
Krishna Midde United States 14 385 3.0× 86 0.7× 48 0.5× 13 0.2× 51 1.1× 28 543

Countries citing papers authored by Meng-Ru Shen

Since Specialization
Citations

This map shows the geographic impact of Meng-Ru Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng-Ru Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng-Ru Shen more than expected).

Fields of papers citing papers by Meng-Ru Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng-Ru Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng-Ru Shen. The network helps show where Meng-Ru Shen may publish in the future.

Co-authorship network of co-authors of Meng-Ru Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Meng-Ru Shen. A scholar is included among the top collaborators of Meng-Ru Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng-Ru Shen. Meng-Ru Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hsu, Ya‐Ting, Pei‐Ying Wu, Yu‐Min Yeh, et al.. (2024). Tight junction protein cingulin variant is associated with cancer susceptibility by overexpressed IQGAP1 and Rac1-dependent epithelial-mesenchymal transition. Journal of Experimental & Clinical Cancer Research. 43(1). 65–65. 6 indexed citations
4.
Chang, Chia‐Ming, Chung‐Ying Lin, Ying‐Wei Wang, et al.. (2024). Clinimetric Properties of the “FIND-NEEDS” to Screen Geriatric Conditions. Gerontology. 70(9). 893–902.
5.
Liang, Yuling, et al.. (2024). Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer. Journal of Biomedical Science. 31(1). 62–62. 10 indexed citations
8.
Chen, Yifan, Li‐Hsien Chen, Jinq‐Chyi Lee, et al.. (2022). Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy. Journal of Medicinal Chemistry. 65(6). 4767–4782. 9 indexed citations
9.
Lin, Peng‐Chan, Shang‐Yin Wu, Bo‐Wen Lin, et al.. (2022). PD-L1 Expression in High-Risk Early-Stage Colorectal Cancer—Its Clinical and Biological Significance in Immune Microenvironment. International Journal of Molecular Sciences. 23(21). 13277–13277. 12 indexed citations
10.
Chen, Po-Chuan, Yu‐Min Yeh, Bo‐Wen Lin, et al.. (2022). The Expression Quantitative Trait Loci in Immune Response Genes Impact the Characteristics and Survival of Colorectal Cancer. Diagnostics. 12(2). 315–315. 4 indexed citations
11.
Lin, Peng‐Chan, et al.. (2022). Cutting-Edge AI Technologies Meet Precision Medicine to Improve Cancer Care. Biomolecules. 12(8). 1133–1133. 12 indexed citations
12.
Sung, Pi‐Shan, Chia‐Jui Yen, Meng-Ru Shen, et al.. (2021). Memantine Protects against Paclitaxel-Induced Cognitive Impairment through Modulation of Neurogenesis and Inflammation in Mice. Cancers. 13(16). 4177–4177. 17 indexed citations
13.
Liu, Yen-Wen, Cheng‐Han Lee, Chi‐Ying Lee, et al.. (2021). Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents. iScience. 24(9). 103082–103082. 6 indexed citations
14.
Chen, Yih‐Fung & Meng-Ru Shen. (2021). The Important Role of Ion Transport System in Cervical Cancer. International Journal of Molecular Sciences. 23(1). 333–333. 4 indexed citations
15.
Yeh, Yu‐Min, Peng‐Chan Lin, Wu‐Chou Su, & Meng-Ru Shen. (2021). CD40 Pathway and IL-2 Expression Mediate the Differential Outcome of Colorectal Cancer Patients with Different CSF1R c.1085 Genotypes. International Journal of Molecular Sciences. 22(22). 12565–12565. 6 indexed citations
16.
Hsu, Ya‐Ting, et al.. (2021). Super-Resolution Microscopy Reveals That Stromal Interaction Molecule 1 Trafficking Depends on Microtubule Dynamics. Frontiers in Physiology. 12. 762387–762387. 5 indexed citations
17.
Yeh, Yu‐Min, Shang‐Hung Chen, Yilin Chen, et al.. (2019). <p>Comprehensive assessment of <em>HER2</em> alteration in a colorectal cancer cohort: from next-generation sequencing to clinical significance</p>. Cancer Management and Research. Volume 11. 7867–7875. 7 indexed citations
18.
Chen, Yun‐Wen, et al.. (2017). STIM1-dependent Ca2+ signaling regulates podosome formation to facilitate cancer cell invasion. Scientific Reports. 7(1). 11523–11523. 26 indexed citations
19.
Meredith, David, et al.. (2003). Molecular and Functional Identification of the Na<sup>+</sup>/H<sup>+</sup> Exchange Isoforms NHE1 and NHE3 in Isolated Bovine Articular Chondrocytes. Cellular Physiology and Biochemistry. 13(4). 215–222. 20 indexed citations
20.
Shen, Meng-Ru, et al.. (2002). Myosin light chain kinase modulates hypotonicity-induced Ca2+ entry and Cl– channel activity in human cervical cancer cells. Pflügers Archiv - European Journal of Physiology. 444(1-2). 276–285. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026